Implications for perioperative patient management
Keynote Speakers:
Prof David Story, University of Melbourne
Dr Michael Margason, Chichester Hospital
March 29, 2025
Dave Story is Professor and Foundation Chair of Anaesthesia at the University of Melbourne and Head of the University Department of Critical Care. Prof Story is the current ANZCA President. His main research interest is clinical and cost-effective approaches to reduce perioperative risk, complications, disability, and mortality.
He also works as a staff Anaesthetist at the Austin Hospital where he provides perioperative care for most procedural specialties including liver transplantation. His love of the outdoors led to research in altitude physiology, subsequent Anaesthesia career, environmental advocacy, and recreational hiking and bike riding.
Dr Margarson trained in London, Oxford, Munich and Sydney and is currently Consultant in Anaesthesia and Critical Care, St Richard's Hospital, Chichester. He was a founder member of the UK Society for Obesity and Bariatric Anaesthesia (SOBA), is currently Vice-president for the European Society for the Peri-operative Care of the Obese Patient (ESPCOP), and active in the sub-committees of the Society for Anesthesia and Sleep Medicine.
His original research interest and MD thesis was on microvascular permeability and rates of transcapillary albumin escape in sepsis. Current interests are mainly focussed around the airway and dosing scalars in anaesthesia for the morbidly obese.
ACS is a one-day single theme meeting offering anaesthetists, intensivists and pain specialists an in-depth look at an area of rapidly changing clinical practice. The theme for ACS 2025 is Advances in Diabetes, Obesity and Metabolic Syndrome management.
Our keynote speakers are Professor David Story and Dr Michael Margason.
Professor Story is the Foundation Chair of Anaesthesia at the University of Melbourne and Head of the University Department of Critical Care. He is the current ANZCA President. He will provide an update on the perioperative management of the patient with Diabetes.
Dr Michael Margason is a Consultant Anaesthetist from Chichester in the UK who is currently on sabbatical to Royal Hobart Hospital in Tasmania. His interests include the anaesthetic management of the obese patient including drug dosing and airway management.
We also have talks on the medical and surgical management of morbid obesity, OSA and NASH.
| 0800 - 0825 | Opening and welcome | Peter Xiang |
| Session 1 - Diabetes management in 2025 | ||
| 0825 - 0855 | Drug treatment of DM | Prof David Story |
| 0855 - 0915 | Advances in medical management of DM in general practice | Prof Rinki Murphy |
| 0915 - 0935 | GLP1's and SGLT2's in the perioperative DM management | Prof David Story |
| 0935 - 1005 | Case discussion | Panel |
| 1005 - 1035 | Morning Break | |
| Session 2 - Obesity Anaesthesia | ||
| 1055 - 1125 | Impact of GLP-1's on Obesity management | TBC |
| 1125 - 1145 | Update on surgical management of morbid obesity | TBC |
| 1145 - 1205 | Nutritional management and patient support in bariatric surgery | TBC |
| 1205 - 1245 | Panel discussion Q&A | |
| 1245 - 1330 | Lunch | |
| Session 3 - Medical and Surgical managment of Obesity | ||
| 1330 - 1400 | Anaesthesia drug dosing in obese patients | Dr Mike Margason |
| 1400 - 1420 | Difficult airway management in morbid obesity | TBC |
| 1420 - 1440 | OSA and OHS in obesity | Dr Mike Margason |
| 1440 - 1500 | Panel discussion Q&A | |
| 1500 - 1530 | Afternoon break | |
| Session 4 - Outcomes and Cases | ||
| 1530 - 1550 | Metabolic dysfunction associated liver diease | Dr Tom Fernandez |
| 1550 - 1610 | Long term outcome from bariatric surgery: lessons learned | TBC |
| 1610 - 1655 | Cases | Panel discussion |
| 0800 - 0825 | Opening and welcome | Peter Xiang |
| Session 1 - Diabetes management in 2025 | ||
| 0825 - 0855 | Drug treatment of DM | Prof David Story |
| 0855 - 0915 | Advances in medical management of DM in general practice | Prof Rinki Murphy |
| 0915 - 0935 | GLP1's and SGLT2's in the perioperative DM management | Prof David Story |
| 0935 - 1005 | Case discussion | Panel |
| 1005 - 1035 | Morning Break | |
| Session 2 - Obesity Anaesthesia | ||
| 1055 - 1125 | Impact of GLP-1's on Obesity management | TBC |
| 1125 - 1145 | Update on surgical management of morbid obesity | TBC |
| 1145 - 1205 | Nutritional management and patient support in bariatric surgery | TBC |
| 1205 - 1245 | Panel discussion Q&A | |
| 1245 - 1330 | Lunch | |
| Session 3 - Medical and Surgical managment of Obesity | ||
| 1330 - 1400 | Anaesthesia drug dosing in obese patients | Dr Mike Margason |
| 1400 - 1420 | Difficult airway management in morbid obesity | TBC |
| 1420 - 1440 | OSA and OHS in obesity | Dr Mike Margason |
| 1440 - 1500 | Panel discussion Q&A | |
| 1500 - 1530 | Afternoon break | |
| Session 4 - Outcomes and Cases | ||
| 1530 - 1550 | Metabolic dysfunction associated liver diease | Dr Tom Fernandez |
| 1550 - 1610 | Long term outcome from bariatric surgery: lessons learned | TBC |
| 1610 - 1655 | Cases | Panel discussion |
Click on the icon below to open the abstract booklet
